RFG Advisory LLC Buys 2,447 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

RFG Advisory LLC lifted its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 309.4% during the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 3,238 shares of the medical equipment provider's stock after purchasing an additional 2,447 shares during the period. RFG Advisory LLC's holdings in Intuitive Surgical were worth $1,604,000 as of its most recent filing with the Securities and Exchange Commission.

Other large investors also recently made changes to their positions in the company. Sycomore Asset Management increased its stake in Intuitive Surgical by 27.4% during the 4th quarter. Sycomore Asset Management now owns 18,945 shares of the medical equipment provider's stock worth $9,214,000 after acquiring an additional 4,079 shares during the period. Castleark Management LLC increased its stake in Intuitive Surgical by 3.4% during the 4th quarter. Castleark Management LLC now owns 90,469 shares of the medical equipment provider's stock worth $47,221,000 after acquiring an additional 2,990 shares during the period. Truist Financial Corp increased its stake in Intuitive Surgical by 3.0% during the 4th quarter. Truist Financial Corp now owns 248,092 shares of the medical equipment provider's stock worth $129,494,000 after acquiring an additional 7,298 shares during the period. Global X Japan Co. Ltd. increased its stake in Intuitive Surgical by 9.8% during the 4th quarter. Global X Japan Co. Ltd. now owns 46,289 shares of the medical equipment provider's stock worth $24,161,000 after acquiring an additional 4,140 shares during the period. Finally, Northeast Investment Management increased its stake in Intuitive Surgical by 3.1% during the 4th quarter. Northeast Investment Management now owns 89,170 shares of the medical equipment provider's stock worth $46,543,000 after acquiring an additional 2,685 shares during the period. Institutional investors own 83.64% of the company's stock.

Insider Activity at Intuitive Surgical

In related news, SVP Mark Brosius sold 489 shares of the business's stock in a transaction dated Friday, March 7th. The stock was sold at an average price of $533.18, for a total value of $260,725.02. Following the completion of the sale, the senior vice president now directly owns 2,091 shares of the company's stock, valued at $1,114,879.38. The trade was a 18.95% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, Director Jami K. Nachtsheim sold 2,400 shares of the business's stock in a transaction dated Thursday, May 1st. The shares were sold at an average price of $520.00, for a total value of $1,248,000.00. Following the completion of the sale, the director now directly owns 6,371 shares of the company's stock, valued at $3,312,920. The trade was a 27.36% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 25,716 shares of company stock valued at $12,831,288 in the last three months. Corporate insiders own 0.70% of the company's stock.

Wall Street Analyst Weigh In

A number of research firms have commented on ISRG. Citigroup restated a "buy" rating and set a $650.00 price objective (up previously from $590.00) on shares of Intuitive Surgical in a research note on Thursday, May 22nd. Evercore ISI decreased their price target on Intuitive Surgical from $510.00 to $470.00 and set an "in-line" rating on the stock in a research note on Wednesday, April 23rd. Piper Sandler decreased their price target on Intuitive Surgical from $670.00 to $575.00 and set an "overweight" rating on the stock in a research note on Wednesday, April 23rd. Barclays decreased their price target on Intuitive Surgical from $684.00 to $635.00 and set an "overweight" rating on the stock in a research note on Thursday, April 24th. Finally, Erste Group Bank upgraded Intuitive Surgical from a "hold" rating to a "buy" rating in a research note on Thursday. Four investment analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and a consensus price target of $596.05.

Intuitive Surgical Price Performance

Shares of NASDAQ ISRG traded up $0.11 during mid-day trading on Thursday, hitting $558.06. 1,241,906 shares of the stock traded hands, compared to its average volume of 1,644,328. The firm has a 50 day simple moving average of $519.52 and a two-hundred day simple moving average of $538.95. Intuitive Surgical, Inc. has a twelve month low of $405.08 and a twelve month high of $616.00. The company has a market cap of $200.02 billion, a PE ratio of 87.06, a price-to-earnings-growth ratio of 5.85 and a beta of 1.67.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last posted its quarterly earnings data on Tuesday, April 22nd. The medical equipment provider reported $1.81 earnings per share for the quarter, topping the consensus estimate of $1.71 by $0.10. Intuitive Surgical had a return on equity of 14.55% and a net margin of 27.81%. The firm had revenue of $2.25 billion during the quarter, compared to analyst estimates of $2.19 billion. During the same period last year, the company posted $1.50 EPS. On average, equities research analysts anticipate that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.